Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders through targeted drug delivery.

Learn to recognize the early signs of childhood meningitis, when to seek help, and how to protect your child with these ...

More than half of all claimants with general musculoskeletal conditions (50.8%) such as "arthritis, muscle or joint pain", ...

This research has the potential to pave the wave for future new treatment options for children with Dravet syndromeNew ...

Researchers from Carnegie Mellon University have developed a cutting-edge method to identify muscle activity in densely ...

When it comes to early detection of cognitive impairment, a new study suggests that the nose knows. Researchers from Mass General Brigham have developed olfactory tests—in which participants sniff ...

Subdural hematoma is an emergency in which bleeding occurs between the brain and skull. Learn how it’s treated and what the ...

Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today provided an update on the company's ...

The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.

The combination of machine learning and a portable system can effectively measure multiple aspects of motor function to identify mild cognitive impairment in older adults.

NAPCO Security Technologies, Inc. , one of the leading designers and manufacturers of high-tech electronic security devices, wireless recurring communication services for intrusion, commercial fire ...

Fatigue is a prevalent yet often underrecognized symptom across neurological and psychiatric disorders, including depression, schizophrenia, multiple ...